| Part Of FDA Advisory Committee Votes 20-0 to Recommend Moderna COVID-19 Vaccine

FDA Holds Open Meeting on Moderna COVID-19 Vaccine, Part 2

The Food & Drug Administration held a virtual open meeting to discuss Moderna’s COVID-19 vaccine and whether it should be recommended for emergency use… read more

The Food & Drug Administration held a virtual open meeting to discuss Moderna’s COVID-19 vaccine and whether it should be recommended for emergency use authorization (EUA). Members of the Vaccines and Related Biological Products Advisory Committee (VRBPA) heard public comments and testimony from Moderna on its vaccine. During this final portion of the meeting, the committee continued their discussion before voting on whether the benefits of the COVID-19 vaccine outweigh the risks for use on individuals 18 years of age or older. After voting by computer, the result was “a favorable vote,” with most of the members voting for use of the vaccine. close

Report Video Issue

People in this video

  • Paula Annunziato Associate Vice President Merck Research Laboratories
  • Prabhakara Atreya Director U.S. Food and Drug Administration->Scientific Advisers and Consultants
  • Juan Banacloche Specialist Mayo Clinic->Infectious Diseases
  • Archana Chatterjee Senior Associate Dean University of South Dakota->Medical School
  • Amanda Cohn Executive Secretary Advisory Committee on Immunization Practices
  • Doran Fink Deputy Director U.S. Food and Drug Administration->Vaccines and Related Biological Products Advisory Committee
  • Oveta Fuller Professor University of Michigan Medical School
  • Hayley Gans Professor Stanford University->Pediatric Infectious Diseases
  • Steven Goodman Professor Stanford University->Epidemiology and Health
  • Mike Kaczynski Project Manager U.S. Food and Drug Administration
  • David Kim Director Centers for Disease Control and Prevention->Immunization Division
  • Jeannette Lee Professor University of Arkansas->Biostatistics
  • Ofer Levy Director Boston Children's Hospital->Precision Vaccines Program
  • Peter W. Marks M.D. Deputy Director U.S. Food and Drug Administration->Center for Biologics Evaluation and Research
  • Pamela McInnes Director National Institutes of Health->National Center for Advancing Translational Sciences
  • Patrick Moore Professor University of Pittsburgh->Cancer Institute
  • Steven Pergam Professor Fred Hutchinson Cancer Research Center
  • Stanley Perlman M.D. Professor University of Iowa->Immunology
  • Eric Rubin Editor in Chief New England Journal of Medicine
  • Sheldon Toubman Assistant Attorney New Haven Legal Assistance
  • Ralph Tripp Associate Professor University of Georgia->Veterinary Infectious Diseases
  • Melinda Wharton Director Centers for Disease Control and Prevention->Immunization Division
  • Marion Gruber Director U.S. Food and Drug Administration->Office of Vaccine Research and Review
  • James Hildreth M.D. President and CEO Meharry Medical College
  • Michael Kurilla Director National Institutes of Health->Division of Clinical Innovation
  • Cody Meissner Professor Tufts University->Infectious Diseases
  • Arnold Monto Professor University of Michigan->Epidemiology
  • Mark Sawyer M.D. Specialist Rady Children's Hospital->Infectious Diseases
More People

Hosting Organization

More Videos From

FDA Advisory Committee Votes 20-0 to Recommend Moderna COVID-19 Vaccine

More information about

FDA Holds Open Meeting on Moderna COVID-19 Vaccine, Part 2

384 Views
Program ID:
507054-4
Category:
Public Affairs Event
Format:
Meeting
Location:
Washington, District of Columbia, United States
First Aired:
Dec 17, 2020 | 2:03pm EST | C-SPAN 3
Last Aired:
Dec 18, 2020 | 12:34am EST | C-SPAN 1

Airing Details

  • Dec 17, 2020 | 2:03pm EST | C-SPAN 3
  • Dec 18, 2020 | 12:34am EST | C-SPAN 1
Purchase a Download

FDA Holds Open Meeting on Moderna COVID-19 Vaccine, Part 2

  • MP3 audio - Standard
    Price:
    $0.99

User Created Clips from This Video